As such, we identified a 4-mRNA signature (considering U2AF1L5, TMEM265, GLB1L and MLF1) based on transcriptome data that could estimate prognosis in patients with NPC, and this signature was identified as an independent prognostic factor for NPC. Here, GLB1L is linked to nasopharyngeal carcinoma.